Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection

被引：0
|
作者：
Mark A. Frye
Charles B. Nemeroff
机构：
[1] Mayo Clinic Alix School of Medicine,Department of Psychiatry & Psychology, Mayo Clinic
[2] University of Texas at Austin Dell Medical School,Department of Psychiatry & Behavioral Sciences
来源：
Neuropsychopharmacology | 2024年 / 49卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：770 / 771
页数：1
相关论文
共 50 条
  • [21] Pharmacogenomic polygenic risk score analysis of antidepressant response and antidepressant-induced mania
    Frye, M.
    Larrabee, B.
    McElroy, S.
    Kung, S.
    Bobo, W.
    Chauhan, M.
    Veldic, M.
    Prieto, M.
    Cuellar-Barboza, A.
    Fuentes, M.
    Bond, D.
    Colby, C.
    Weinshilboum, R.
    Tye, S.
    Ahmed, A.
    Rummans, T.
    Biernacka, J.
    BIPOLAR DISORDERS, 2017, 19 : 114 - 114
  • [22] RATIONAL SELECTION OF PCR-BASED PLATFORMS FOR PHARMACOGENOMIC TESTING
    De Monaco, A.
    D'Orta, A.
    Fierro, C.
    Di Paolo, M.
    Cilenti, L.
    Di Francia, R.
    WORLD CANCER RESEARCH JOURNAL, 2014, 1 (04)
  • [23] Applicability of pharmacogenomic testing in the treatment of major depressive disorder
    Ramos, S.
    Sousa, D.
    Mendes, J.
    EUROPEAN PSYCHIATRY, 2020, 63 : S655 - S656
  • [24] Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
    Stanek, E. J.
    Sanders, C. L.
    Taber, K. A. Johansen
    Khalid, M.
    Patel, A.
    Verbrugge, R. R.
    Agatep, B. C.
    Aubert, R. E.
    Epstein, R. S.
    Frueh, F. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) : 450 - 458
  • [25] COMBINATORIAL PHARMACOGENOMIC TESTING IMPROVES GENERALIZED ANXIETY DISORDER TREATMENT RESPONSE AND DECREASES BENZODIAZAPINE USE
    Tiwari, Arun
    Zai, Clement
    Zai, Gwyneth
    Cheema, Sheraz
    Braganza, Nicole
    Mueller, Daniel
    Passariello, Catherine
    Brown, Lisa
    Dechairo, Bryan
    Kennedy, James L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S933 - S933
  • [26] Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D
    Clark, S. L.
    Adkins, D. E.
    Aberg, K.
    Hettema, J. M.
    McClay, J. L.
    Souza, R. P.
    van den Oord, E. J. C. G.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (06) : 1151 - 1162
  • [27] Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
    Cazzola, Mario
    Rogliani, Paola
    Calzetta, Luigino
    Matera, Maria Gabriella
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 261 - 271
  • [28] Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study
    Cernat, Alexandra
    Samaan, Zainab
    Abelson, Julia
    Ramdyal, Amanada
    Shaikh, Hadia
    Vanstone, Meredith
    JOURNAL OF COMMUNITY GENETICS, 2024, 15 (03) : 293 - 309
  • [29] METABOLOMICS-INFORMED-PHARMACOGENOMIC-BASED PREDICTIONS OF RESPONSE TO COMBINATION ANTIDEPRESSANT THERAPIES: A MACHINE
    Grant, C.
    Joyce, J.
    Kaddurah-Daouk, R.
    Skime, M.
    Biernacka, J.
    Mayes, T.
    Carmody, T.
    Croarkin, P.
    Wang, L.
    Weinshilboum, R.
    Bobo, W.
    Trivedi, M.
    Athreya, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S68 - S69
  • [30] Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
    J L McClay
    D E Adkins
    K Åberg
    S Stroup
    D O Perkins
    V I Vladimirov
    J A Lieberman
    P F Sullivan
    E J C G van den Oord
    Molecular Psychiatry, 2011, 16 : 76 - 85
12345